Militia Capital Partners LP Purchases 7,000 Shares of National Health Investors, Inc. $NHI

Militia Capital Partners LP increased its position in National Health Investors, Inc. (NYSE:NHI) by 53.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 20,100 shares of the real estate investment trust’s stock after acquiring an additional 7,000 shares during the period. Militia Capital Partners LP’s holdings in National Health Investors were worth $1,535,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. NewEdge Advisors LLC grew its holdings in National Health Investors by 28.7% during the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 345 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in National Health Investors by 9.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock valued at $18,460,000 after purchasing an additional 21,851 shares during the period. Jane Street Group LLC grew its holdings in National Health Investors by 1,728.4% during the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after purchasing an additional 65,885 shares during the period. Cetera Investment Advisers grew its holdings in National Health Investors by 6.1% during the second quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock valued at $336,000 after purchasing an additional 275 shares during the period. Finally, American Century Companies Inc. grew its holdings in National Health Investors by 2.2% during the second quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust’s stock valued at $1,349,000 after purchasing an additional 420 shares during the period. Institutional investors own 62.51% of the company’s stock.

Insider Activity

In other National Health Investors news, CEO D. Eric Mendelsohn acquired 1,500 shares of the stock in a transaction dated Friday, June 5th. The shares were acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Robert A. Mccabe, Jr. acquired 890 shares of the stock in a transaction dated Monday, June 15th. The stock was acquired at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This represents a 2.06% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is owned by insiders.

Analysts Set New Price Targets

NHI has been the subject of several recent research reports. BMO Capital Markets cut their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a report on Monday. Wells Fargo & Company cut their price target on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a report on Monday, June 1st. Cantor Fitzgerald reissued an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. Weiss Ratings lowered National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday. Finally, Truist Financial cut their price target on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a report on Friday, June 12th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $84.57.

National Health Investors Price Performance

Shares of National Health Investors stock opened at $71.51 on Wednesday. The stock’s 50-day simple moving average is $76.80 and its 200-day simple moving average is $79.97. National Health Investors, Inc. has a 52 week low of $67.94 and a 52 week high of $91.38. The company has a market capitalization of $3.47 billion, a price-to-earnings ratio of 23.07, a PEG ratio of 3.80 and a beta of 0.52. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.39). National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The business had revenue of $115.13 million during the quarter, compared to analysts’ expectations of $70.22 million. During the same quarter in the previous year, the firm earned $1.15 earnings per share. National Health Investors’s revenue was up 28.9% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, analysts expect that National Health Investors, Inc. will post 4.93 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 5.1%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s payout ratio is presently 118.71%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.